Research and Development work in Eczacıbaşı Monrol Nuclear Products Industry and Trade Inc.  covers investigation and production of radiopharmaceuticals already existing in the market,their equivalents or new radiopharmaceuticals . Other studies related to enhancement of production and quality control methods of our registered products and services, reducing production costs, reducing environmental effects are also carried out under R&D. 

I-131 MIBG (Metaiodobenzylguanidine) – Our MON-MIBG(D) product has already been registered and will be marketed soon. Studies with MON-MIBG (T) which is used for therapy purposes is going on. This radiopharmaceutical is used for the diagnosis and therapy of  phaeochromocytomas and neuroblastomas

ECD ( Ethyl cysteinate dimer) – This is a kit to be labeled with Tc99m for the evaluation of regional cerebral perfusion abnormalities in patients with central nervous system disorders. It is expected to be marketed soon.